Capstone Therapeutics Announces Initiation of Dosing for AEM-28 Phase 1b/2a Human Clinical Trial in Refractory Hypercholesterolemic Subjects
11 juin 2014 12h47 HE
|
Capstone Therapeutics
TEMPE, Ariz., June 11, 2014 (GLOBE NEWSWIRE) -- Capstone Therapeutics (OTCQB:CAPS) ("the Company") and its joint venture affiliate, LipimetiX Development, LLC ("JV"), announced today the initiation of...
Capstone Therapeutics Announces Operating Update Conference Call
16 mai 2014 13h00 HE
|
Capstone Therapeutics
TEMPE, Ariz., May 16, 2014 (GLOBE NEWSWIRE) -- Capstone Therapeutics (OTCQB:CAPS); (the "Company"), will hold a conference call and webcast on Wednesday, May 21, 2014 at 4:30 pm EDT. The call may be...
Capstone Therapeutics Announces Initiation of Dosing for AEM-28 Phase 1 Human Clinical Trial in LDL/non-HDL Cholesterol Reduction
08 avr. 2014 09h00 HE
|
Capstone Therapeutics
TEMPE, Ariz., April 8, 2014 (GLOBE NEWSWIRE) -- Capstone Therapeutics (OTCQB:CAPS) ("the Company") and its joint venture affiliate, LipimetiX Development, LLC ("JV"), announced today the initiation of...
Capstone Therapeutics Announces Operating Update Conference Call, Planned Initiation of AEM-28 Phase 1 Study and Fiscal Year 2013 Financial Results
27 mars 2014 09h00 HE
|
Capstone Therapeutics
TEMPE, Ariz., March 27, 2014 (GLOBE NEWSWIRE) -- Capstone Therapeutics (OTCQB:CAPS) ("the Company") and its joint venture affiliate, LipimetiX Development, LLC ("JV"), today will hold a conference...
Capstone Therapeutics Announces Operating Update Conference Call
24 mars 2014 14h29 HE
|
Capstone Therapeutics
TEMPE, Ariz., March 24, 2014 (GLOBE NEWSWIRE) -- Capstone Therapeutics (OTCQB:CAPS); (the "Company"), will hold a conference call and webcast on Thursday, March 27, 2014 at 4:30 pm EDT. The call may...
Capstone Therapeutics Announces a LipimetiX Development, LLC Presentation at the American Heart Association Scientific Sessions: Pre-Clinical Data Demonstrating Significant Post Treatment Benefit of AEM-28 on Established Atherosclerotic Lesions
19 nov. 2013 11h00 HE
|
Capstone Therapeutics
TEMPE, Ariz. and BOSTON, Nov. 19, 2013 (GLOBE NEWSWIRE) -- Capstone Therapeutics' (OTCQB:CAPS) joint venture, LipimetiX Development, LLC, today announced the presentation of pre-clinical data...
Capstone Therapeutics to Hold Quarterly Operating Update Conference Call
12 nov. 2013 15h47 HE
|
Capstone Therapeutics
TEMPE, Ariz., Nov. 12, 2013 (GLOBE NEWSWIRE) -- Capstone Therapeutics (OTCQB:CAPS); (the "Company"), will hold a conference call and webcast on Thursday, November 21, 2013 at 4:30 pm EST. The call may...
Capstone Therapeutics Will Provide an Operating Update and Announces Second Quarter 2013 Financial Results
14 août 2013 08h30 HE
|
Capstone Therapeutics
TEMPE, Ariz., Aug. 14, 2013 (GLOBE NEWSWIRE) -- Capstone Therapeutics (OTCQB:CAPS) (the "Company"), today will hold a conference call and webcast to provide an operating update and announced financial...
Capstone Therapeutics to Hold Quarterly Operating Update Conference Call
07 août 2013 14h16 HE
|
Capstone Therapeutics
TEMPE, Ariz., Aug. 7, 2013 (GLOBE NEWSWIRE) -- Capstone Therapeutics (OTCQB:CAPS); (the "Company"), will hold a conference call and webcast on Wednesday, August 14, 2013 at 4:30 pm EDT. The call may...
Capstone Therapeutics Will Provide an Operating Update and Announces First Quarter 2013 Financial Results
15 mai 2013 09h30 HE
|
Capstone Therapeutics
TEMPE, Ariz., May 15, 2013 (GLOBE NEWSWIRE) -- Capstone Therapeutics (OTCQB:CAPS); (the "Company"), today will hold a conference call and webcast to provide an operating update and announced financial...